High-risk nonmelanoma skin cancers

Dermatologic Surgery

Volumn 24, Issue 12, 1998, Pages 1272-1292

  Demetrius, R W ^a   Randle, H W ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOSARCOMA; CANCER MORTALITY; CANCER RECURRENCE; DERMATOFIBROMA; DERMATOFIBROSARCOMA PROTUBERANS; FIBROXANTHOMA; HIGH RISK PATIENT; HUMAN; MERKEL CELL TUMOR; METASTASIS; MUCINOUS CARCINOMA; PAGET SKIN DISEASE; PRIORITY JOURNAL; REVIEW; SEBACEOUS CARCINOMA; SKIN CANCER; SQUAMOUS CELL CARCINOMA;

EID: 0032446740     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1998.tb00001.x     Document Type: Review

References (79)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994 ; 30: 774–8.
2. Randle HW. Basal cell carcinoma. Identification and treatment of the high‐risk patient. Dermatol Surg 1996 ; 22: 255–61.
3. Preston DS, Stern RS. Nonmelanoma cancers of the skin. N Engl J Med 1992 ; 327: 1649–62.
4. Boring CC, Squires TS, Tong T. Cancer statistics, 1991. CA Cancer J Clin 1991 ; 41: 19–36.
5. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994 ; 30: 774–8.
6. Schwartz RA, Stoll HL Jr. Squamous cell carcinoma. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, eds. Dermatology in General Medicine, 4th ed. New York: McGraw‐Hill, 1993 ; 821–39.
7. Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992 ; 26: 976–90.
8. Granstrom G, Aldenborg F, Jeppsson PH. Influence of embryonal fusion lines for recurrence of basal cell carcinomas in the head and neck. Otolaryngol Head Neck Surg 1986 ; 95: 76–82.
9. Lange PG Jr. Management of squamous cell carcinomas and lymph node evaluation. In: Wheeland RG, ed. Cutaneous Surgery. Philadelphia: WB Saunders Company, 1994 ; 752–92.
10. Johnson WC, Helwig EB. Adenoid squamous cell carcinoma (adenoacanthoma). A clinicopathologic study of 155 patients. Cancer 1966 ; 19: 1639–50.
11. Bernstein SC, Lim KK, Broadland DG, Heidelberg KA. The many faces of squamous cell carcinoma. Dermatol Surg 1996 ; 22: 243–54.
12. Terashi H, Kurata S, Tadokoro T, et al. Perineural and neural involvement in skin cancers. Dermatol Surg 1997 ; 23: 259–64.
13. Dinehart SM, Chu DZ, Maners AW, Pollack SV. Immunosuppression in patients with metastatic squamous cell carcinoma from the skin. J Dermatol Surg Oncol 1990 ; 16: 271–4.
14. Perez GL, Randle HW. Natural history of squamous cell carcinoma of the skin: case report. Cutis 1995 ; 55: 34–6.
15. Brodland DG, Zitelli JA. Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992 ; 27: 241–8.
16. Geohas J, Roholt NS, Robinson JK. Adjuvant radiotherapy after excision of cutaneous squamous cell carcinoma. J Am Acad Dermatol 1994 ; 30: 633–6.
17. Toker C. Trabecular carcinoma of the skin. Arch Dermatol 1972 ; 105: 107–10.
18. Haag ML, Glass LF, Fenske NA. Merkel cell carcinoma. Diagnosis and treatment. Dermatol Surg 1995 ; 21: 669–83.
19. Ratner D, Nelson BR, Brown MD, Johnson TM. Merkel cell carcinoma. J Am Acad Dermatol 1993 ; 29: 143–56.
20. Bielamowicz S, Smith D, Abemayor E. Merkel cell carcinoma: an aggressive skin neoplasm. Laryngoscope 1994 ; 104: 528–32.
21. Shaw JH, Rumball E. Merkel cell tumour: clinical behaviour and treatment. Br J Surg 1991 ; 78: 138–42.
22. O'Connor WJ, Brodland DG. Merkel cell carcinoma. Dermatol Surg 1996 ; 22: 262–7.
23. Queirolo P, Gipponi M, Peressini A, et al. Merkel cell carcinoma of the skin. Treatment of primary, recurrent, and metastatic disease: review of clinical cases. Anticancer Res 1997 ; 17: 673–7.
24. Suntharalingam M, Rudoltz MS, Mendenhall WM, Parsons JT, Stringer SP, Million RR. Radiotherapy for Merkel cell carcinoma of the skin of the head and neck. Head Neck 1995 ; 17: 96–101.
25. Morrison WH, Peters LJ, Silva EG, Wendt CD, Ang KK, Goepfert H. The essential role of radiation therapy in securing locoregional control of Merkel cell carcinoma. Int J Radiat Oncol Biol Phys 1990 ; 19: 583–91.
26. Messina JL, Reintgen DS, Cruse CW, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997 ; 4: 389–95.
27. Helwig EB. Atypical fibroxanthoma. Tex J Med 1963 ; 59: 664–7.
28. Helwig EB, May D. Atypical fibroxanthoma of the skin with metastasis. Cancer 1986 ; 57: 368–76.
29. Brown MD, Swanson NA. Treatment of malignant fibrous histiocytoma and atypical fibrous xanthomas with micrographic surgery. J Dermatol Surg Oncol 1989 ; 15: 1287–92.
30. Fretzin DF, Helwig EB. Atypical fibroxanthoma of the skin. A clinicopathologic study of 140 cases. Cancer 1973 ; 31: 1541–52.
31. Davis JL, Randle HW, Zalla MJ, Roenigk RK, Brodland DG. A comparison of Mohs micrographic surgery and wide excision for the treatment of atypical fibroxanthoma. Dermatol Surg 1997 ; 23: 105–10.
32. Brown MD, Swanson NA. Treatment of malignant fibrous histiocytoma and atypical fibrous xanthomas with micrographic surgery. J Dermatol Surg Oncol 1989 ; 15: 1287–92.
33. O'Brien JE, Stout AP. Malignant fibrous xanthomas. Cancer 1964 ; 17: 1445–55.
34. Weiss SW, Enzinger FM. Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 1978 ; 41: 2250–66.
35. Rutgers EJ, Kroon BB, Albus‐Lutter CE, Gortzak E. Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol 1992 ; 18: 241–8.
36. Gloster HM Jr, Harris KR, Roenigk RK. A comparison between Mohs micrographic surgery and wide surgical excision for the treatment of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1996 ; 35: 82–7.
37. Taylor HB, Helwig EB. Dermatofibrosarcoma protuberans. A study of 115 cases. Cancer 1962 ; 15: 717–25.
38. Parker TL, Zitelli JA. Surgical margins for excision of dermatofibrosarcoma protuberans. J Am Acad Dermatol 1995 ; 32: 233–6.
39. Ding J, Hashimoto H, Enjoji M. Dermatofibrosarcoma protuberans with fibrosarcomatous areas. A clinicopathologic study of nine cases and a comparison with allied tumors. Cancer 1989 ; 64: 721–9.
40. Connelly JH, Evans HL. Dermatofibrosarcoma protuberans. A clinicopathologic review with emphasis on fibrosarcomatous areas. Am J Surg Pathol 1992 ; 16: 921–5.
41. Wolfe JT, Wick MR, Campbell RJ. Sebaceous carcinoma of the oculocutaneous adnexa and extraocular skin. In: Wick MR, ed. Pathology of Unusual Malignant Cutaneous Tumors. New York: Marcel Dekker, 1985 ; 77–106.
42. Wick MR, Goellner JR, Wolfe JT III, Su WP. Adnexal carcinomas of the skin. II. Extraocular sebaceous carcinomas. Cancer 1985 ; 56: 1163–72.
43. Wolfe JT III, Yeatts RP, Wick MR, Campbell RJ, Waller RR. Sebaceous carcinoma of the eyelid. Errors in clinical and pathologic diagnosis. Am J Surg Pathol 1984 ; 8: 597–606.
44. Nelson BR, Hamlet KR, Gillard M, Railan D, Johnson TM. Sebaceous carcinoma. J Am Acad Dermatol 1995 ; 33: 1–15.
45. Kass LG, Hornblass A. Sebaceous carcinoma of the ocular adnexa. Surv Ophthalmol 1989 ; 33: 477–90.
46. Rao NA, Hidayat AA, McLean IW, Zimmerman LE. Sebaceous carcinomas of the ocular adnexa: a clinicopathologic study of 104 cases, with five‐year follow‐up data. Hum Pathol 1982 ; 13: 113–22.
47. Ratz JL, Luu‐Duong S, Kulwin DR. Sebaceous carcinoma of the eyelid treated with Mohs' surgery. J Am Acad Dermatol 1986 ; 14: 668–73.
48. Yount AB, Bylund D, Pratt SG, Greenway HT. Mohs micrograph excision of sebaceous carcinoma of the eyelids. J Dermatol Surg Oncol 1994 ; 20: 523–9.
49. Hodgkinson DJ, Soule EH, Woods JE. Cutaneous angiosarcoma of the head and neck. Cancer 1979 ; 44: 1106–13.
50. Goldberg DJ, Kim YA. Angiosarcoma of the scalp treated with Mohs micrographic surgery. J Dermatol Surg Oncol 1993 ; 19: 156–8.
51. Caro MR, Stubenrauch CH Jr. Hemangioendothelioma of the skin. Arch Dermatol Syph 1945 ; 51: 295–304.
52. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer 1987 ; 59: 1046–57.
53. Barttelbort SW, Stahl R, Ariyan S. Cutaneous angiosarcoma of the face and scalp. Plast Reconstr Surg 1989 ; 84: 55–9.
54. Chanda JJ. Extramammary Paget's disease: prognosis and relationship to internal malignancy. J Am Acad Dermatol 1985 ; 13: 1009–14.
55. Heymann WR. Extramammary Paget's disease. Clin Dermatol 1993 ; 11: 83–7.
56. Crocker HR. Paget's disease affecting the scrotum and penis. Trans Pathol Soc London 1889 ; 40: 187–91.
57. Coldiron BM, Goldsmith BA, Robinson JK. Surgical treatment of extramammary Paget's disease. A report of six cases and a reexamination of Mohs micrographic surgery compared with conventional surgical excision. Cancer 1991 ; 67: 933–8.
58. Helm KF, Goellner JR, Peters MS. Immunohistochemical stains in extramammary Paget's disease. Am J Dermatopathol 1992 ; 14: 402–7.
59. Ewing TL. Paget's disease of the vulva treated by combined surgery and laser. Gynecol Oncol 1991 ; 43: 137–40.
60. Perniciaro C, Buskirk S. Extramammary Paget's disease treated with radiotherapy. J Derm Treatment 1993 ; 4: 164–5.
61. Goldstein DJ, Barr RJ, Santa Cruz DJ. Microcystic adnexal carcinoma: a distinct clinicopathologic entity. Cancer 1982 ; 50: 566–72.
62. Billingsley EM, Fedok F, Maloney ME. Microcystic adnexal carcinoma. Case report and review of the literature. Arch Otolaryngol Head Neck Surg 1996 ; 122: 179–82.
63. Burns MK, Chen SP, Goldberg LH. Microcystic adnexal carcinoma. Ten cases treated by Mohs micrographic surgery. J Dermatol Surg Oncol 1994 ; 20: 429–34.
64. Pujol RM, LeBoit PE, Su WP. Microcystic adnexal carcinoma with extensive sebaceous differentiation. Am J Dermatopathol 1997 ; 19: 358–62.
65. Cooper PH. Sclerosing carcinomas of sweat ducts (microcystic adnexal carcinoma). Arch Dermatol 1986 ; 122: 261–4.
66. Cooper PH, Mills SE, Leonard DD, et al. Sclerosing sweat duct (syringomatous) carcinoma. Am J Surg Pathol 1985 ; 9: 422–33.
67. Mayer MH, Winton GB, Smith AC, Lupton GP, Parry EL, Shagets FW. Microcystic adnexal carcinoma (sclerosing sweat duct carcinoma). Plast Reconstr Surg 1989 ; 84: 970–5.
68. Hazen PG, Bass J. Microcystic adnexal carcinoma: successful management using Mohs' micrographically‐controlled surgery. Int J Dermatol 1994 ; 33: 801–2.
69. Mendoza S, Helwig EB. Mucinous (adenocystic) carcinoma of the skin. Arch Dermatol 1971 ; 103: 68–78.
70. Karimipour DJ, Johnson TM, Kang S, Wang TS, Lowe L. Mucinous carcinoma of the skin. J Am Acad Dermatol 1997 ; 36: 323–6.
71. Lennox B, Pearse AGE, Richards HGH. Mucin‐secreting tumours of the skin: with special reference to so‐called mixed‐salivary tumour of the skin and its relation to hidradenoma. J Pathol Bacteriol 1952 ; 64: 865–80.
72. Baandrup U, Sogaard H. Mucinous (adenocystic) carcinoma of skin. Dermatologica 1982 ; 164: 338–42.
73. Weber PJ, Hevia O, Gretzula JC, Rabinovitz HC. Primary mucinous carcinoma. J Dermatol Surg Oncol 1988 ; 14: 170–2.
74. Balin AK, Fine RM, Golitz LE. Mucinous carcinoma. J Dermatol Surg Oncol 1988 ; 14: 521–4.
75. Cohen KL, Peiffer RL, Lipper S. Mucinous sweat gland adenocarcinoma of the eyelid. Am J Ophthalmol 1981 ; 92: 183–8.
76. Grossman JR, Izuno GT. Primary mucinous (adenocystic) carcinoma of the skin. Arch Dermatol 1974 ; 110: 274–6.
77. Boi S, De Concini M, Detassis C. Mucinous sweat‐gland adenocarcinoma of the inner canthus: a case report. Ann Ophthalmol 1988 ; 20: 189–90.
78. Abe S, Matsumoto Y, Fujita T. Primary mucinous carcinoma of the skin. Plast Reconstr Surg 1997 ; 99: 1160–4.
79. Yeung KY, Stinson JC. Mucinous (adenocystic) carcinoma of sweat glands with widespread metastasis. Case report with ultrastructural study. Cancer 1977 ; 39: 2556–62.